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1. INTRODUCTION 
Shchelkunov et al. [1] compare the genes present in 
variola major virus (strain India-1967) and vaccinia 
virus (strains Copenhagen and WR) that encode pro- 
teins involved in the modulation of the host response. 
Comparison of the sequence of the genome of variola 
virus, the causative agent of smallpox, with that of vac- 
cinia virus, the smallpox vaccine, provides an opportu- 
nity to identify the genes that may have contributed to 
the high pathogenicity of variola virus. Shchelkunov et 
al. conclude that the genes encoding receptors for inter- 
leukin-l/I (IL-l/I), tumour necrosis factor (TNF) and 
interferon-y (IFN-y) are present and presumably active 
in variola virus. However, a detailed analysis of the 
DNA sequence of variola virus, deposited by the au- 
thors in the EMBL Data Library (accession number 
X69198), reveals that some of these genes are in fact 
fragmented or deleted in the variola genome, which 
substantially changes the conclusions of the paper. 
2. TNF RECEPTOR 
During evolution poxviruses have acquired two genes 
encoding soluble TNF receptors which are both active 
in cowpox [Z]. One such gene (B28R) is fra~ented in 
vaccinia virus Copenhagen [3], but its homolo~e is 
intact and probably active in variola virus (gene G4R) 
[l]. This is an important finding since blocking TNF 
action with a soluble receptor will probably increase 
viral pathogenicity, as has been shown for the closely 
related T2 protein of Leporipoxviruses [4], The second 
gene encoding a soluble TNF receptor is present, al- 
though fragmented and inactive, in vaccinia virus 
strains Copenhagen (A53R) and WR (SalF16R) [3,5,6]. 
Remarkably, this gene is deleted from variola major 
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virus strains India-1967 [ 11 and Harvey [7] (Fig. 1A). 
Although we do not yet understand the reasons for the 
acquisition of a second TNF receptor gene, it is likely 
that this provided an advantage for virus replication in 
the host. Consequently, the fact that variola virus has 
lost one TNF receptor gene, although it contains an- 
other intact TNF receptor, cannot be ignored. 
3. IL-1B RECEPTOR 
The vaccinia IL-l@ receptor is encoded by gene BlSR 
in vaccinia virus strain WR [8] and gene B16R in the 
Copenhagen strain 131, although in Copenhagen the 
gene is defective due to a non-sense mutation near the 
N-terminus. The variola virus homologue is not gene 
B14R reported by Shchelkunov et al. [I], which encodes 
a protein of 149 amino acids with only 17% amino acid 
identity to the 326 amino acid vaccinia IL-l/? receptor, 
but is a gene found downstream. Remarkably, the vari- 
ola gene encoding the IL-l/? receptor is fragmented into 
eight pieces by non-sense and frameshift mutations, and 
the initiator methionine is absent owing to the deletion 
of the thymidylate residue in the ATG codon (Fig. 1 B). 
The variola virus genes B 15R and B 17R reported in the 
DNA sequence correspond to two of these fragments 
[l]. These mutations make it impossible for this gene to 
encode a soluble IL-l/3 receptor. This result is unex- 
pected since loss of the soluble IL-I/I receptor would be 
predicted to enhance those aspect of the immune re- 
sponse mediated by IL-lp and, therefore, attenuate the 
virus, as has been shown in mice infected through the 
intracranial route with a vaccinia virus mutant contain- 
ing a disrupted B15R gene [9]. However, it correlates 
well with results obtained in our laboratory in which 
deletion of the B15R gene from vaccinia virus increases 
the severity of the infection in mice inoculated through 
the intranasal route, probably due to the detrimental 
effects produced by increased circulating IL-IF during 
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Fig. I. Schematic alignment of the open reading frames in the genomes 
of variola and vaccinia viruses. 
infection [lo]. This intranasal route of inoculation has 
some similarity with the infection of humans with vari- 
ola virus, which usually entered via the respiratory track 
and led to a systemic infection [l 11. Perhaps disruption 
of the IL-1s receptor gene in variola virus contributed 
to its high pathogenicity. 
4. CONCLUSIONS 
Variola virus strain India-1967 is predicted to express 
an active IFN-)I and one TNF receptor [l]. However, 
the analysis presented here shows that a second TNF 
receptor is deleted and the IL-lp receptor is fragmented. 
Disruption or deletion of nine genes in variola virus has 
been reported as the major difference with vaccinia 
virus over a 21.8 kbp fragment of the Harvey strain [7], 
and in this region there are only 29 nucleotide changes 
between variola strains Harvey and India-1967. A more 
detailed comparison of the complete DNA sequences of 
variola and vaccinia viruses is required to identify not 
only the conserved genes, but also those that are frag- 
mented or deleted, to know whether inactivation of 
genes is a general phenomenon that may have contrib- 
uted to the high pathogenicity of variola virus. 
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